for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

Hi All,

As for those who have an interest in the landfill situation in the UK, my parents are doing building work on their house, and are using skip bins to get rid of waste .... they used to pay 40 for a 10 ton skip, now it's 120 .... because the government are charging 8 per ton for the landfill ....

Cheers,
PM

Strange thumbing through today's posts to see it dominated by an affair of importance to B**G but merely gnat-like to SEO. Very significant report from KBC Peel Hunt which explains and quantifies the Starpol opportunity in mugh greater detail that Evolution; noted that source is Company (historic data) and KBC Peel Hunt. I note that there assumptions re Greenseal roll-out are somewhat scaled back whilst they are very bullish indeed about Starpol Note the following: "the addition of this 'second leg' reduces the risk of failure for the group and due to the cross selling opportunities that exist should actually increase the likelihood of success for both parts of the group - the only way to make an MAP seal on Biotec's products is to use RF welding.

Interested in views re where the sp would have got to with Biotec if it hadn't moved from the 4p to 6p range on the back of Greenseal. Talk of an EBIT contribution of euro400m would suggest perhaps to the current level anyway. What is clear is that it should be an exciting Autumn as the scenario unfolds.

Eric

SEO, SEO, WEEEEED.

Research Page updated

29) Stanelco Debuts Impact-Resistant Petal Pack

https://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread

ZZZZZZZZzzzzzzzzzzzz ZZZZZZZZZZZZzzzzzzzzzzzz

Believe we are establishing a nice base at present level taking into account the lack of news. Just needs a bit if patience. The US will come for Greenseal and then onwards and upwards!

Eric

Paul, thanks that explained it. :)

Sorry eric I fell asleep I just been reading all the flower stuff from pm1 its a good read if you cant sleep.

Paul "the google king" Masterson!

Phoned the Bioprogress lawyers office this morning to clarify the court case appeals, seems I was correct; the only thing Stanelco have been allowed to appeal is Judge Floyds decision not to allow their prior art argument. He felt it was not relevant as it was not in the public domain(the manual was out of print and very obscure), he did let them appeal this decision though.

The appeal judges will be friends of Floyd as the patent industry is very tight knit, most are actually based in the same office block in New Square, London; do any of you really think they'll overturn a logical decision from one of their friends?

20 million pounds please, thank you very much:-)

PM1 . The land fill tax is actually 15 ish per tonne with a minimum charge of 3 tonnes, so if you only have a tonne of waste you pay for 3!!

shamona, are you insinuating that appeal court judges will be prejudicial in court? that they will not listen to any evidence and back floyds judgement just because he is a mate? that is highly insulting.

I'm not saying that, i'm saying they'd need a very good reason to disagree with one of their own; I can't see them not agreeing with the original decision as nothing has changed.

that's not what it sounded like.........

Stanelco fit the bill nicely under option 1 :)

From TMF today ....

Tomorrow's Growth Share Winners

By Maynard Paton (TMFMayn)
September 7, 2005


All private investors dream of finding the next GlaxoSmithKline (LSE: GSK). In 1965, the company was worth 64m, had started to dabble in the then fledgling pharmaceutical industry and was sixteen years away from hitting the big time with ulcer treatment Zantac. These days, Glaxo is worth 79b -- up a stunning 123,000% in 40 years -- a gain that excludes some mighty dividends collected in the meantime!

Dynamic growth shares such as a 1965 Glaxo will I hope form a major part of Champion Shares -- the exciting, brand new investment service from The Motley Fool. Here's my quick five-point guide to finding some of the great winners of tomorrow:

1. Growing industry or revolutionising an existing sector: A dynamic growth company must have long-term expansion opportunities. Glaxo was there at the dawn of the emerging pharmaceutical industry. Tesco (LSE: TSCO), on the other hand, was already selling food when it saw the advantages of larger, out-of-town locations. It then helped lead a revolution away from the traditional corner shop and has since lead another revolution selling non-food goods! Tesco, for what it's worth, has seen its market value improve 75,400% since 1965!

I reckon specialists involved in, for instance, the Internet, 3G, microchips, software or healthcare, or a firm 'shaking the rules' in conventional areas such as retail, finance or transport, could make for a great Champion Shares 'fast grower'. In fact, I'm increasingly finding new issues as a fertile hunting ground for growth. Plenty of smaller companies are now joining the market and offering what I consider to be ground-floor opportunities in promising, innovative sectors.

2. Rapid and organic sales growth: I'm not too interested in a blue-sky gamble. Instead, I want companies that have already demonstrated their potential. Rapid top-line progress is by far the best evidence for me, especially if it's organic and based on deals with respected customers. Admittedly, I can live with a 'fast grower' not earning a profit. In my experience, superior sales growth can eliminate losses in time -- but I've got to be sure breakeven comes sooner rather than later!

3. Market leader: This is important. The worst growth share to hold is an over-rated Johnny-come-lately that lacks the resources to sustain its progress. I want a sector 'first mover' and/or front runner. If the company is profitable, I'll look for high operating margins for evidence of a competitive advantage. Whatever, I'll certainly study the company for protective 'barriers' -- such as patents, branding or customer switching costs -- that can keep rivals at bay.

I also believe a key element to any fast-growing firm is management. I want to see the founder -- with all his or her entrepreneurial and creative talent -- at the helm and turning their growth-share ambition into reality. Certainly among smaller growth companies, running with 'founder management' is all important to me.

4. Net cash and cash generation: Fast growers are always prone to hitting speed bumps. If trouble does strike, I want the company to recover smartly. A substantial net cash pile, I feel, is one of the most reliable ways of surviving any difficulties. That said, I really prefer to spot trouble at a business before it occurs!

Something few growth investors ever check is cash flow. I've witnessed numerous fast-expanding companies haemorrhage cash, which to me suggested their rapid sales/earnings growth was nothing more than an accounting illusion. Indeed, here are five growth share impostors I spotted before they crashed and burned following terrible cash management.

5. Cheap valuation: Essentially I want to buy growth at a reasonable price. But judging how much to pay for a company expanding at, say, 20% a year, is tricky. Depending on how long the growth rate lasts, 30, 40, or even 50 times earnings, could be justified. In fact, you could have bought go-go Google (Nasdaq: GOOG) last year at almost 60 times earnings... yet tripled your money within twelve months! To a certain extent, there'll be no hard and fast valuations rules for my Champion Shares fast growers. But I'll do some rough projections and ensure the shares have room to produce a 100% gain within three to five years.

What now?

So which shares am I investigating as possible Champion Shares fast growers? Unfortunately, the growth opportunities I'm actively monitoring can't be revealed here. But what I can say is that there is no shortage of possibilities. A quick trawl on a popular share-filter website listed over 400 quoted companies that had doubled their top line within the last five years!

The companies I'm watching will be eventually revealed when the Champion Shares service launches in the near future -- though I can't promise any will produce anything like Glaxo's 123,000% return! To learn more about Champion Shares and the opportunities it will recommend, just pop your e-mail address in the box below.

Maynard owns shares in GlaxoSmithKline. Sadly, he bought them a long time after 1965 but hopes also to find the next Glaxo soon!

LOL !!

LOL!

Open day at the nursing home !

Danlyboy@ntlworld.com

the thing with Paul's very long posts is that when you are not in the mood, or you simply do not have the time, then they can be simply way to tedious.....
HOWEVER......when you are in the mood and/or do have the time, and you read thru the posts in some detail......you will realise that one way or another you are gaining some useful information.

I recently spent half a day looking up the NatureWorks-Cargill website, to see whether they are a dangerous competitor to SEO, and then after ingesting what i was looking for; i realised that most of the overall content of the material had been posted on this thread by the sometimes over-exubirant resident poster.....

I think he's an android that never sleeps....